October 2017

Global Bone Cancer Treatment Market – Growth, Trends and Forecasts (2017 – 2022)

Purchase Report
Single user license
Team license
Corporate license

Bone Cancer Treatment Market

The market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was estimated to be USD XX million in 2015 and is forecasted to reach USD XX million by 2021.

The National Cancer Institute reports an estimated 3300 new cases and 1490 deaths in 2016, due to bone cancer in the U.S. The survival rate of bone cancer, however, has improved over the past few years, with a strong drug pipeline for bone cancer treatment. The market is expected to witness a lucrative growth throughout the forecast period.

Global Bone Cancer Treatment - Market Dynamics

The report details several factors driving and restraining the market, some of which are discussed below.


  • Rapidly aging population
  • Increased usage of combination therapies


  • High cost of treatment
  • Less awareness about effective treatment strategies

Market Segmentation

The global bone cancer treatment market has been segmented by type of treatment and end-users. The treatment segment is further segmented into surgery, chemotherapy (Doxorubicin, Cisplatin, Carboplatin, Etoposide, Ifosfamide, Cyclophosphamide, Methotrexate, Vincristine), radiation therapy and targeted therapy (Imatinib, Denosumab). The end-user segment consists of multispecialty hospitals and cancer research institutes. The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.

Some of the key players in the market are:

  • Novartis AG
  •  Amgen
  •  F. Hoffmann-La Roche Ltd.
  •  Bayer-Algeta
  •  Merrion Pharmaceuticals Plc.
  •  Ablynx
  •  Genta Incorporated
  •  Galapagos NV
  •  Catena Pharmaceuticals Inc.
  •  Digna Biotech S.L.
  •  Medivir AB
  •  Amura Holdings
  • Others

What the Report Offers

  • Market definition, along with identification of key drivers and restraints for the market.
  • Market analysis with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
  • A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
  • An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
No related reports available.
Purchase Report
Single user license
Team license
Corporate license
Our Clients Include View All

Looking to Customize Report?